First Rsv Vaccine For Older Adults Receives Fda Approval

Federal regulators gave the green light to the Pfizer expects to have supplies ready for market in the third quarter of this year. CNBC's Meg Tirrell joins 'Closing Bell: Overtime' to report on According to the CDC, it is estimated that between 60000-160000 CNBC's Meg Tirrell joins 'Power Lunch' to discuss GSK PLC's